×
0 0 0 0 -0.0155440414507771 -0.0155440414507771 -0.0414507772020725 -0.0621761658031088
Stockreport

Capricor licenses additional patent applications from Cedars-Sinai Medical Center for cellular and exosome-based technologies [Seeking Alpha]

CAPRICOR THERAPEUTICS (CAPR)  More Company Research Source: Seeking Alpha
Last capricor therapeutics earnings: 5/10 04:00 pm Check Earnings Report
US:NASDAQ Investor Relations: capricor.com/investors
PDF Capricor licenses additional patent applications from Cedars-Sinai Medical Center for cellular and exosome-based technologiesCapricor Therapeutics (NASDAQ:CAPR) hasadded seven new patent applications to its existing Exclusive License Agreements with Cedars-Sinai Medical Center for technologies related to cardiosphere-derived cells (CDCs) and CDC-derived extracellular vesicles, including exosomes.The Exclusive License Agreements grant Capricor exclusive worldwide rights to commercially develop and market CDCs as well as exosomes, comprisingCAP-1002 andCAP-2003.The new patent applications will enable Capricor to develop new therapeutic indications in Duchenne muscular dystrophy, ventricular tachyarrhythmia, cancer and age-related disorders.Shares of CAPR are up8% premarket on modest volume.See all stocks on the move »Now read:Dynavax: Gearing Up For Its Next Big Run » [Read more]

IMPACT SNAPSHOT EVENT TIME: CAPR
Last Price
Price Change
Price Change %
Volume Shares
Max Up
Max Down
Volume Ratio
%
Performance comparison Updated
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
LAST PRICE
VWAP
High:
MAX UP
High:
Low:
MAX DOWN
Low:
%
POST NEWS RANGE
%
PRICE CHANGE

PRICE CHANGE PERCENTAGE


S&P 500 (SPX)

%

VOLUME RATIO
%

VOLUME (SHARES)
TICKS

AVG SHARES PER TRADE

Don't Miss Out On The Next BIG Stock Move
EVENT DAY
Event Day Chart will not be displayed beyond 90-day period of the event
PERFORMANCE SINCE EVENT
TIME AND VELOCITY ANALYSIS